AFRM vs IRD · P/E 590, rev $3.22B vs rev $11.0M
Affirm Holdings Inc (AFRM) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. IRD currently screens at market cap $35.7M.
Not investment advice. Open the AFRM and IRD stock pages for the full models.
Not investment advice.